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1. Analysis of pathway specific complement activation in rodents is feasible with ELISA-based systems, 
allowing in vivo and in vitro analysis of complement activation and inhibition with minute amounts of 
blood. (this thesis) 
2. The basal levels of complement factors and activation fragments are affected by host complement 
turnover, acute injury and progressive conditions such as inflammation (this thesis) 
3. A rat model of experimental renal I/RI is driven by serum MBL, whereas in a similar mouse model 
systemic and local arms of complement play an important role (this thesis). 
4. Anaphylatoxin receptor C5L2 contributes to renal I/RI through specific modulation of inflammatory 
cell responses and promotion of inflammation within the injured kidney. (this thesis) 
5. Properdin binds injured glomeruli independent of C3 and IgG, establishing that properdin may act as a 
pattern recognition molecule in vivo and may direct complement activation. (this thesis) 
6. Female mice of common strains have inherently low terminal pathway activity, in part explaining the 
gender specific protection against experimental renal I/RI in mice. (this thesis) 
7. Dietary interventions modulate the hepatic expression of complement components resulting in impaired 
terminal pathway activity in mice. (this thesis) 
8. “(…) we have now arrived at a new perception of this evolutionarily refined pathway that reaches far 
beyond its role in host defence to tissue development, waste disposal, and immune modulation. (Daniel 
Ricklin, Nature Reviews Nephrology 12, 383–401, 2016) 
9. There is abundant pre-clinical and clinical data demonstrating the role of complement activation in the 
development of acute kidney injury (James W McCullough, Seminars in Nephrology, Nov; 33(6), 
2013). 
10. The alternative pathway should be regarded as a dual system, namely a recognition pathway principally 
similar to the classical and lectin pathways, and an amplification mechanism, well known, but 
quantitatively probably more important than generally recognized. (Morten Harboe,  Journal of 
cellular and molecular medicine 12, 1074 – 84, 2008) 
11. From experimental and clinical evidence to date, it seems that the circulating pool of complement 
underlies much of the pathology traditionally associated with glomerular disease (…). In contrast, the 
renal tubulointerstitium is the domain of local synthesis of complement (Steven Sacks, Journal of the 
American Society of Nephrology 19, 1865 – 1869, 2008). 
12.  “Measurement is the first step that leads to control and eventually to improvement. If you can’t 
measure something, you can’t understand it. If you can’t understand it, you can’t control it. If you can’t 
control it, you can’t improve it.” (H. James Harrington, CIO September 1999 p.19.) 
13. "Life is and will ever remain an equation incapable of solution, but it contains certain known factors." 
(Nicola Tesla, ‘A Machine to End War’, Liberty magazine February 9, 1935) 
14. “Everything starts from somewhere, although many physicists disagree” (Sir Terry Pratchett, 
Hogfather, chapter 1, 1996) 
15. "Blut is ein ganz besonderer Saft" (Johann Wolfgang von Goethe, Faust I, Verse 1740, 1808) 
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